Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-risk Papillary Thyroid Cancer”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableEnrolling By InvitationNCT06261190
What this trial is testing

Active Surveillance for Low-risk Papillary Thyroid Carcinoma

Who this might be right for
Thyroid CancerPapillary Thyroid Carcinoma
National Cancer Center, Korea 499
Not applicableLooking for participantsNCT06725576
What this trial is testing

Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma

Who this might be right for
Thyroid Cancer, Papillary
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 201
Not applicableLooking for participantsNCT07376837
What this trial is testing

Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study

Who this might be right for
Thyroid Papillary Carcinoma
University Health Network, Toronto 30
Large-scale testing (Phase 3)Looking for participantsNCT06082180
What this trial is testing

A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer

Who this might be right for
Thyroid CancerRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 1,199
Not applicableActive Not RecruitingNCT04624477
What this trial is testing

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

Who this might be right for
Papillary Thyroid CancerPapillary Thyroid CarcinomaPapillary Microcarcinoma of the Thyroid
University Health Network, Toronto 450
Not applicableStudy completedNCT04500925
What this trial is testing

The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience

Who this might be right for
Well Differentiated Thyroid CarcinomaPapillary Thyroid Cancer
Tel-Aviv Sourasky Medical Center 301
Not applicableStudy completedNCT03300284
What this trial is testing

Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 186
Large-scale testing (Phase 3)Active Not RecruitingNCT01398085
What this trial is testing

IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

Who this might be right for
Thyroid CancerThyroid Neoplasms
University College, London 504
Not applicableActive Not RecruitingNCT06271044
What this trial is testing

A. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS

Who this might be right for
to Omit Radioiodine Treatment Safely in Patients With Low -Risk Papillary Thyroid Cancer With Seize of 11-20mm
Helsinki University Central Hospital 61
Not applicableLooking for participantsNCT06316895
What this trial is testing

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Cancer
Chinese PLA General Hospital 3,772
Early research (Phase 1)UnknownNCT00103155
What this trial is testing

Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer

Who this might be right for
Head and Neck Cancer
University of California, San Francisco
Not applicableUnknownNCT04354324
What this trial is testing

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Cancer
Zhujiang Hospital 254
Not applicableEnded earlyNCT05003856
What this trial is testing

Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule

Who this might be right for
Benign Thyroid Gland NeoplasmRecurrent Thyroid Gland CarcinomaThyroid Gland Follicular Tumor of Uncertain Malignant Potential+2 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Not applicableNot Yet RecruitingNCT07536412
What this trial is testing

Decision Aid Efficacy in Low Risk Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer (DTC)Papillary Thyroid MicrocarcinomaPapillary Thyroid Carcinoma
University of Maryland, Baltimore 34
Not applicableNot Yet RecruitingNCT06730893
What this trial is testing

Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer

Who this might be right for
Thyroid CancerPapillary Thyroid Carcinoma
National Cancer Center, Korea 310
Not applicableLooking for participantsNCT07140757
What this trial is testing

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Who this might be right for
Low RiskPapillary Thyroid CancerRadiofrequency Ablation
M.D. Anderson Cancer Center 50
Not applicableActive Not RecruitingNCT03271892
What this trial is testing

Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer Stage I
University Health Network, Toronto 200
Large-scale testing (Phase 3)UnknownNCT00415233
What this trial is testing

High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer

Who this might be right for
Head and Neck Cancer
University College, London 438
Testing effectiveness (Phase 2)Looking for participantsNCT06087068
What this trial is testing

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

Who this might be right for
Thyroid CancerSurgeryRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 140
Next Page